Dimensional Fund Advisors LP Argenx Se Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Argenx Se stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 40,220 shares of ARGX stock, worth $36.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,220

Previous 35,993 11.74%

Holding current value

$36.5 Million

Previous $19.8 Million 49.52%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$538.64 - $768.0 $2.28 Million - $3.25 Million	4,227 Added 11.74%	40,220 $29.7 Million
Q2 2025 Aug 12, 2025	BUY	$532.27 - $656.65 $2 Million - $2.46 Million	3,752 Added 11.64%	35,993 $19.8 Million
Q1 2025 May 13, 2025	BUY	$571.0 - $671.75 $4.18 Million - $4.91 Million	7,312 Added 29.33%	32,241 $19.1 Million
Q4 2024 Feb 13, 2025	BUY	$520.52 - $638.33 $2.31 Million - $2.84 Million	4,445 Added 21.7%	24,929 $15.3 Million
Q3 2024 Nov 07, 2024	BUY	$434.22 - $551.9 $475,905 - $604,882	1,096 Added 5.65%	20,484 $11.1 Million

Q2 2024 Aug 09, 2024	BUY	$356.01 - $451.55 $511,942 - $649,328	1,438 Added 8.01%	19,388 $8.34 Million
Q1 2024 May 10, 2024	BUY	$356.95 - $413.29 $25,700 - $29,756	72 Added 0.4%	17,950 $7.07 Million
Q4 2023 Feb 07, 2024	BUY	$338.91 - $506.01 $616,477 - $920,432	1,819 Added 11.33%	17,878 $6.8 Million
Q3 2023 Nov 09, 2023	BUY	$369.35 - $548.43 $787,454 - $1.17 Million	2,132 Added 15.31%	16,059 $7.9 Million
Q2 2023 Aug 09, 2023	BUY	$360.14 - $422.58 $84,632 - $99,306	235 Added 1.72%	13,927 $5.43 Million
Q1 2023 May 12, 2023	BUY	$334.23 - $403.65 $226,607 - $273,674	678 Added 5.21%	13,692 $5.1 Million
Q4 2022 Feb 09, 2023	BUY	$342.17 - $402.31 $728,479 - $856,517	2,129 Added 19.56%	13,014 $4.93 Million
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $327,069 - $377,149	953 Added 9.6%	10,885 $3.84 Million
Q2 2022 Aug 12, 2022	SELL	$269.58 - $378.88 $147,999 - $208,005	-549 Reduced 5.24%	9,932 $3.76 Million
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $1.34 Million - $1.84 Million	5,247 Added 100.25%	10,481 $3.31 Million
Q4 2021 Feb 09, 2022	BUY	$272.01 - $353.03 $2,176 - $2,824	8 Added 0.15%	5,234 $1.83 Million
Q3 2021 Nov 12, 2021	SELL	$295.0 - $350.58 $83,190 - $98,863	-282 Reduced 5.12%	5,226 $1.58 Million
Q2 2021 Aug 12, 2021	SELL	$257.11 - $319.92 $522,961 - $650,717	-2,034 Reduced 26.97%	5,508 $1.66 Million
Q1 2021 May 14, 2021	SELL	$268.3 - $380.31 $130,930 - $185,591	-488 Reduced 6.08%	7,542 $2.08 Million
Q4 2020 Feb 25, 2021	BUY	$248.13 - $308.36 $1.99 Million - $2.48 Million	8,030 New	8,030 $2.36 Million

Others Institutions Holding ARGX

# of Institutions

526

Shares Held

26M

Call Options Held

590K

Put Options Held

320K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Argenx Se Transaction History